Results 251 to 260 of about 1,434,677 (298)

A Fatal Case of Pulmonary Tumor Thrombotic Microangiopathy Originating From Primary Bladder Adenocarcinoma. [PDF]

IJU Case Rep
Kodani H, Sekii Y, Inoguchi Y, Tomiyama E, Takayama H, Yasuhara Y.   +5 more
europepmc   +1 more source

High altitude pulmonary hypertension: overlap with other types of pulmonary hypertension and implications for treatment. [PDF]

BMJ Med
Forbes LM, Lahm T.
europepmc   +1 more source

Sotatercept as a Treatment for Pulmonary Hypertension Associated With Connective Tissue Disease and ILD. [PDF]

Open Respir Arch
Vargas-Ursúa F, Cruz-Utrilla A, Tenes A.   +2 more
europepmc   +1 more source

Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in pulmonary arterial hypertension. [PDF]

Am J Respir Crit Care Med
Alotaibi M, Harvey LD, Nichols WC, Hemnes A, Sun W, Begzati A, Long T, Havulinna AS, Niiranen TJ, Desai AA, Cheng S, Jain M, Chan SY.   +12 more
europepmc   +1 more source

Treprostinil: Mechanism of Action, Clinical, and Translational Science. [PDF]

Clin Transl Sci
Sameed M, Waleed M, Colomy V.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pulmonary Hypertension

Medical Clinics of North America, 2019
Pulmonary hypertension (PH) is a chronic and progressive disease that presents like many other lung diseases, often leading to a delay in diagnosis, and therefore a delay in optimal therapy. This article provides a review of PH for internists, covering clinical presentation, diagnostic algorithm, different types of PH, and overview of treatments.
Darlene, Kim, M Patricia, George
openaire   +2 more sources